Get the Stockscreener App
40.68
2.73%
1.08
Scholar Rock Holding Corp stock is traded at $40.68, with a volume of 845.54K.
It is up +2.73% in the last 24 hours and down -18.64% over the past month.
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
See More
Previous Close:
$39.60
Open:
$39.99
24h Volume:
845.54K
Relative Volume:
0.48
Market Cap:
$4.95B
Revenue:
$47.30M
Net Income/Loss:
$-408.73M
P/E Ratio:
-11.34
EPS:
-3.5865
Net Cash Flow:
$-303.86M
1W Performance:
-3.60%
1M Performance:
-18.64%
6M Performance:
-17.52%
1Y Performance:
+25.56%
1-Day Range:
$39.32
$41.35
1-Week Range:
$39.20
$42.81
52-Week Range:
$27.07
$61.76
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Name
Scholar Rock Holding Corp
Sector
Industry
Phone
857-259-3860
Address
301 BINNEY STREET, CAMBRIDGE, MA
Compare SRRK vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
40.68 | 4.95B | 47.30M | -408.73M | -303.86M | -3.5865 |
VRTX
Vertex Pharmaceuticals Inc
|
509.72 | 129.19B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
237.78 | 94.93B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
801.11 | 82.48B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
848.35 | 53.35B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
371.37 | 42.01B | 5.76B | 514.49M | 1.10B | 4.4813 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-21-26 | Initiated | Canaccord Genuity | Buy |
| Jan-09-26 | Initiated | Citigroup | Buy |
| Nov-18-25 | Initiated | Wolfe Research | Outperform |
| Oct-09-25 | Initiated | BofA Securities | Buy |
| Sep-17-25 | Initiated | Barclays | Overweight |
| Sep-15-25 | Initiated | Leerink Partners | Outperform |
| Aug-21-25 | Resumed | Jefferies | Buy |
| Jul-30-25 | Resumed | Raymond James | Strong Buy |
| Jul-17-25 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-26-24 | Reiterated | H.C. Wainwright | Buy |
| Oct-07-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-28-24 | Initiated | Raymond James | Strong Buy |
| Oct-25-23 | Upgrade | Jefferies | Hold → Buy |
| Apr-03-23 | Resumed | Piper Sandler | Overweight |
| Sep-19-22 | Resumed | H.C. Wainwright | Buy |
| Jul-12-22 | Initiated | Truist | Buy |
| Mar-23-22 | Initiated | H.C. Wainwright | Buy |
| Dec-22-21 | Downgrade | Jefferies | Buy → Hold |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Jan-11-21 | Initiated | Credit Suisse | Outperform |
| Jan-06-21 | Initiated | JP Morgan | Overweight |
| Mar-12-20 | Initiated | Robert W. Baird | Outperform |
View All
Scholar Rock Holding Corp Stock (SRRK) Latest News
Scholar Rock Holding Corporation (SRRK) stock price, news, quote and history - Yahoo Finance Australia
Director Katie Peng proposes selling 1,006 shares of Scholar Rock (SRRK). - Stock Titan
Form 4 Scholar Rock Holding Corp For: 26 September By Investing.com - Investing.com Canada
Form 4 Scholar Rock Holding Corp For: 26 September By Investing.com - Investing.com Nigeria
No common shares appear in Scholar Rock (SRRK) COO Keith Woods’s reported position after a gift to a trust. - Stock Titan
No payment changed hands when Scholar Rock (SRRK) CEO David Hallal transferred 36,652 shares to a family trust. - Stock Titan
Scholar Rock Holding Corporation (SRRK) stock price, news, quote and history - uk.finance.yahoo.com
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Bank of America Corp DE Takes $53.47 Million Position in Scholar Rock Holding Corporation $SRRK - marketbeat.com
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Scholar Rock Holding (SRRK) Won FDA Approval, Is The Stock Still Trading At A Discount? - simplywall.st
Scholar Rock (NASDAQ: SRRK) Updates FDA Safety Requirements for ISEMBYLD Post-Approval - Kalkine Media
Scholar Rock: Reiterating 'Strong Buy' On FDA Approval SMA And Expansions Now In Play - Seeking Alpha
Scholar Rock clarifies post-marketing requirements for ISEMBYLD after FDA approval - Investing.com
Scholar Rock Updates FDA Post-Marketing Safety Requirements for ISEMBYLD Following Investor Call Correction - Kalkine Media
Form 8K Scholar Rock Holding Corp For: 14 September By Investing.com - Investing.com UK
Form 8K Scholar Rock Holding Corp For: 14 September By Investing.com - Investing.com India
SRRK Shares Surge 12% After FDA Approval of Isembyld for Spinal Muscular Atrophy - GuruFocus
Scholar Rock jumps 12% after FDA approves isembyld for spinal muscular atrophy (SRRK:NASDAQ) - Seeking Alpha
symbol__ Stock Quote Price and Forecast - CNN
Scholar Rock (SRRK) Gains FDA Approval for Isembyld Amid High Pr - GuruFocus
Second Time’s The Charm: FDA Clears Scholar Rock’s SMA Drug Ahead Of Deadline, SRRK Soars 15% After-Hours - Stocktwits
FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment - GlobeNewswire Inc.
Scholar Rock at citigroup biopharma summit: FDA decision nears By Investing.com - Investing.com Nigeria
BMO reiterates Scholar Rock stock Outperform on SMA drug uptake - Investing.com
BMO reiterates Scholar Rock stock Outperform on SMA drug uptake By Investing.com - Investing.com India
Scholar Rock at citigroup biopharma summit: FDA decision nears - Investing.com
BMO reiterates Scholar Rock stock Outperform on SMA drug uptake By Investing.com - Investing.com UK
Scholar Rock at citigroup biopharma summit: FDA decision nears By Investing.com - Investing.com UK
Scholar Rock Holding Corporation $SRRK Stock Position Lifted by Squarepoint Ops LLC - marketbeat.com
BMO reiterates Scholar Rock stock Outperform on SMA drug uptake By Investing.com - Investing.com Nigeria
Scholar Rock at cantor global healthcare conference: approval clock nears By Investing.com - Investing.com South Africa
Scholar Rock at cantor global healthcare conference: approval clock nears By Investing.com - Investing.com India
Scholar Rock at cantor global healthcare conference: approval clock nears By Investing.com - Investing.com UK
SRRK Reiterates by HC Wainwright & Co. -- Price Target Maintained at $65 - GuruFocus
Scholar Rock's (SRRK) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Legal & General Group Plc Invests $3.36 Million in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock (SRRK) Gains FDA Fast Track for Apitegromab Amid Hi - GuruFocus
Oruka Therapeutics (NASDAQ: ORKA) Launches Up to $500M Common Stock Offering via TD Cowen - Kalkine Media
122,223 Shares in Scholar Rock Holding Corporation $SRRK Acquired by The Manufacturers Life Insurance Company - marketbeat.com
Beaconlight Capital LLC Makes New Investment in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding (SRRK) Stock Dropped, So What Is Behind The Latest Attention? - simplywall.st
Bank of New York Mellon Corp Acquires New Shares in Scholar Rock Holding Corporation $SRRK - MarketBeat
104,346 Shares in Scholar Rock Holding Corporation $SRRK Acquired by Man Group plc - MarketBeat
Algert Global LLC Grows Stock Holdings in Scholar Rock Holding Corporation $SRRK - marketbeat.com
Jupiter Topco LLC Invests $123.28 Million in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock (NASDAQ:SRRK) Shares Up 5.8%Still a Buy? - MarketBeat
Nicholas Investment Partners LP Purchases New Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
9,494,084 Shares in Scholar Rock Holding Corporation $SRRK Purchased by BlackRock Inc. - marketbeat.com
Scholar Rock Holding Corp stock hits 52-week high at 58.52 USD - Investing.com Canada
Scholar Rock Holding Corp Stock (SRRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Scholar Rock Holding Corp Stock (SRRK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Mohammed Qatanani | Officer |
Jul 06 '26 |
Proposed Sale |
54.68 |
11,704 |
639,975 |
0 |
| FLIER JEFFREY S. | Director |
Jul 01 '26 |
Sale |
53.88 |
3,053 |
164,490 |
27,856 |
| Peng Katie | Director |
Jul 01 '26 |
Sale |
53.88 |
5,446 |
293,405 |
34,301 |
| Joshua Reed | Director |
Jul 01 '26 |
Proposed Sale |
54.79 |
3,053 |
167,274 |
0 |
| Jeffrey S. Flier | Director |
Jul 01 '26 |
Proposed Sale |
54.79 |
3,053 |
167,274 |
0 |
| Kristina Burow | Director |
Jul 01 '26 |
Proposed Sale |
54.79 |
3,053 |
167,274 |
0 |
| Michael Gilman | Director |
Jul 01 '26 |
Proposed Sale |
54.79 |
2,544 |
139,385 |
0 |
| Katie Peng | Director |
Jul 01 '26 |
Proposed Sale |
54.79 |
5,446 |
298,386 |
0 |
| Gilman Michael | Director |
Jul 01 '26 |
Sale |
53.87 |
2,544 |
137,058 |
59,511 |
| Burow Kristina | Director |
Jul 01 '26 |
Sale |
53.74 |
3,053 |
164,064 |
114,657 |
2.44%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):